Publications hub
Find our publications, laboratory reports, meeting minutes and statements, and scheduling decisions.
We’re still confirming the best location for some of our content. Can't find what you’re looking for? You can also:
-
search our Resources
-
use the site search bar in the top right of this screen for more results.
Filter results
You can narrow down the results using the filters
Topic
- (-) COVID-19 vaccines (1)
- Advisory bodies and committees (285)
- Scheduling (123)
- Medical devices (86)
- Medicines (37)
- In Vitro Diagnostic medical devices (IVDs) (36)
- Complementary medicines (34)
- Advertising (33)
- Manufacturing (29)
- Prescription medicines (29)
- OTC medicines (28)
- Legislation (24)
- Medicines safety (22)
- Therapeutic goods regulation (17)
- Medical devices safety (15)
- Safety (15)
- Regulatory compliance (13)
- Biologicals (12)
- Medicinal cannabis hub (11)
- Labelling and packaging (8)
- Disinfectants/Sterilants (6)
- Listed medicines (6)
- Non-prescription medicines (5)
- Other therapeutic goods (5)
- Sunscreens (4)
- Blood and blood components (3)
- TGA conformity assessment certification (3)
- Unapproved therapeutic goods (3)
- Clinical trials (2)
- Electronic submissions (2)
- Fees and payments (2)
- Metal-on-metal hip replacement implants hub (2)
- Alert/Advisory (1)
- Blood safety (1)
Type
Published date
Search
1 result(s) found, displaying 1 to 1
- PublicationsTherapeutic Goods (Poisons Standard) (COVID-19 Vaccine - Moderna) (Elasomeran and Davesomeran) Labelling Exemption 2023This instrument is made under section 39 of the current Poisons Standard.